Sirius Medical announces major funding round to further accelerate sales growth and new product development

Sirius Pintuition® – Moving from Localization to Surgical Marker Navigation

Eindhoven, Netherlands – 28 March 2023 – Our portfolio company Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The funding will accelerate the worldwide growth of their product Pintuition and support further product development. Holland Capital acted as lead investor for this series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, and a major investment from Sirius Medical’s management and team. Norgine Ventures joined as a new investor in this round to support further commercial roll-out.

Sirius’ state-of-the-art navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and more than 5,000 successful Pintuition procedures across Western Europe and the US, the company experienced an unprecedented growth in revenue in 2022, attributable to Pintuition’s ease of use, straightforward implementation, and its unmatched precision in locating the target tissue.

Sirius Medical has done a great job developing and bringing to market the Pintuition technology with a strong commercial start”, says Peter Stein, Chief Executive of Norgine Ventures. “Norgine Ventures is excited to support Sirius Medical’s leadership and their vision to deliver cost effective solutions in surgery.”

We are excited about the market potential for surgical marker navigation,” says Jan Frens van Giessel, partner at Holland Capital. “We believe that the Pintuition technology and its future innovations will significantly improve surgery of non-palpable tumors for patients, physicians and improve the care for cancer patients.”

Having become the fastest growing company in the industry is a clear confirmation of the unique benefits that our technology brings to both patients and physicians,” says Bram Schermers, CEO at Sirius Medical.  “Supported by this latest funding round I am confident that our highly talented and motivated team will further drive the adoption of Pintuition across the globe.”

About Sirius Medical

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared.  Sirius Medical is rapidly expanding with over 100 centers and an international sales network in Europe and the USA. www.sirius-medical.com 

About Holland Capital

Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

Interview with Margot Engels

Interview with Margot Engels

Investing in healthcare has pros and cons. In addition to the financial aspect, social responsibility is at least as important. Substantive knowledge of the product, the sector and market movements are therefore essential, as Margot Engels also knows.

Kids Lodge Acquires BSO Wijs

Kids Lodge Acquires BSO Wijs

Kids Lodge Acquires BSO Wijs   Amsterdam/Houten, March 22, 2024 – Our portfolio company Kids Lodge has acquired the childcare organization BSO Wijs. The acquisition allows Kids Lodge to further expand its childcare activities in the Utrecht region. With 10...

Complementary duo on the sofa

Complementary duo on the sofa

Complementary duo on the sofa: an inspiring interview with our managing partners, Hubert Verbeek and Ewout Prins!
A candid conversation on the sofa; the place where they prefer to get to know other entrepreneurs through informal “sofa sessions” and where personal questions are central.

Holland Capital invests in the growth ambitions of Adjust

Holland Capital invests in the growth ambitions of Adjust

Holland Capital invests in the growth ambitions of Adjust   Amsterdam/Amstelveen, January 23rd , 2024 – Holland Capital invests in Adjust, a renowned procurement and contract management advisory firm serving the public, semi-public, and private sectors. Holland...

Emixa Announces Rebranding of Affiliated Companies

Emixa Announces Rebranding of Affiliated Companies

Emixa Announces Rebranding of Affiliated Companies   Naarden, January 8, 2024 – Our portfolio company Emixa, the leading Digital Transformation partner, announces the rebranding of its affiliated companies under the Emixa brand name in the Benelux and UK region....

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01